PubRank

John W Greiner

Author PubWeight™ 21.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine 2006 1.38
2 Costimulatory molecules as adjuvants for immunotherapy. Front Biosci 2006 1.37
3 Physical activity and cancer prevention : pathways and targets for intervention. Sports Med 2008 1.24
4 Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12. Cancer Res 2009 1.12
5 Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses. Clin Cancer Res 2008 1.09
6 Identification of an interferon-gamma-inducible carcinoembryonic antigen (CEA) CD8(+) T-cell epitope, which mediates tumor killing in CEA transgenic mice. Cancer Res 2002 1.04
7 Chitosan solution enhances the immunoadjuvant properties of GM-CSF. Vaccine 2007 0.94
8 In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines. Biomaterials 2010 0.93
9 Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis. Cancer Immunol Immunother 2014 0.93
10 Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice. Cancer Res 2004 0.93
11 Intratumoral immunotherapy of established solid tumors with chitosan/IL-12. J Immunother 2010 0.91
12 Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccines. Mutat Res 2005 0.88
13 TRICOM vector based cancer vaccines. Curr Pharm Des 2006 0.87
14 Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancer. Cancer Res 2002 0.87
15 The antitumor and immunoadjuvant effects of IFN-alpha in combination with recombinant poxvirus vaccines. Clin Cancer Res 2009 0.86
16 The immunocytokine NHS-IL12 as a potential cancer therapeutic. Oncotarget 2014 0.83
17 Enhanced expression of lymphotactin by CD8+ T cells is selectively induced by enhancer agonist peptides of tumor-associated antigens. Cytokine 2003 0.83
18 Energy restriction and exercise differentially enhance components of systemic and mucosal immunity in mice. J Nutr 2008 0.82
19 Exercise enhances vaccine-induced antigen-specific T cell responses. Vaccine 2008 0.82
20 Inhibition of TGF-β1 signaling promotes central memory T cell differentiation. J Immunol 2013 0.81
21 Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity. J Interferon Cytokine Res 2008 0.81
22 Combination of physical activity, nutrition, or other metabolic factors and vaccine response. Front Biosci 2007 0.80
23 Distinct effects of saracatinib on memory CD8+ T cell differentiation. J Immunol 2012 0.80